Darunavir in patients who failed on fos-amprenavir: efficacy at week 48 (2008)
De Wit, S, Delforge, M, Kabeya, K, Necsoi, C, Clumeck, N
No abstract available.
Ribera, E, Florence, E, De Wit, S, Castagna, A, Ryan, B, Vanaken, H, ...
No abstract available.
Florence, E, De Wit, S, Castagna, A, Ribera, E, Hill, AM, Ryan, R, ...
No abstract available.
Konopnicki, D, Manigart, Y, Scheen, R, Delforge, M, Barlow, P, De Wit, S, ...
No abstract available.
Petoumenos, K, Fontas, E, Worm, SW, Weber, R, De Wit, S, Bruyand, M, ...
No abstract available.
Vercauteren, J., Derdelinckx, I., Sasse, A., Bogaert, M., Ceunen, H., De Roo, A., ...
This study is the first prospective study to assess the prevalence, epidemiology, and risk factors of HIV-1 drug resistance in newly diagnosed HIV-infected patients in Belgium. In January 2003 it was...
Class of antiretroviral drugs and the risk of myocardial infarction (2007)
Friis-Møller, N., Reiss, P., Sabin, C.A., Weber, R., D'Arminio Monfort, A., El-Sadr, W., ...
Background: We have previously demonstrated an association between combination antiretroviral therapy and the risk of myocardial infarction. It is not clear whether this association differs according...
HIV and syphilis: when to perform a lumbar puncture (2007)
Libois, A., De Wit, S., Poll, B., Garcia, F., Florence, E., Del Rio, A., ...
OBJECTIVES: The objectives of this study were to determine predictive factors for neurosyphilis in HIV-infected patients with syphilis and optimize the use of lumbar puncture. STUDY DESIGN: The...
Mocroft, A., Soriano, V., Rockstroh, J., Reiss, P., Kirk, O., De Wit, S., ...
Background: Increases in deaths due to liver-related disease (LRD) among HIV-infected individuals have been reported while the influence of combination antiretroviral therapy (cART) on LRD is...
Sturen van de afvoerverdeling op het splitsingspunt Pannerdensche Kop met een bypass (2004)
In de toekomst krijgt Nederland te maken met hogere rivierafvoeren en een stijgende zeespiegel. Als gevolg van deze ontwikkelingen zullen de waterstanden op de rivieren stijgen. De maatgevende afvoer...
Derdelinckx, I., Van Laethem, K., Maes, B., Schrooten, Y., De Wit, S., Florence, E., ...
Not the final published version
Combination antiretroviral therapy and the risk of myocardial infarction (2003)
Friis-Møller, N., Sabin, C.A., Weber, R., D'Arminio Monforte, A., El-Sadr, W.M., Reiss, P., ...
Background: It remains controversial whether exposure to combination antiretroviral treatment increases the risk of myocardial infarction. Methods: In this prospective observational study, we...
Derdelinckx, I., Van Laethem, K., Maes, B., Schrooten, Y., De Schouwer, K., De Wit, S., ...
In this study we evaluated the performance of the VERSANT HIV-1 Resistance Assays (LiPA) in detecting drug resistance in therapy-naive HIV-infected patients diagnosed in Belgium in 2000. We compared...
Van Laethem, Y., Hermans, P., De Wit, S., Goosens, H., Clumeck, N.
Twenty-one patients were included in an open randomized study comparing vancomycin 1 g bd with teicoplanin 400 mg daily in severe methicillin-resistant Staphylococcus aureus infections. The median...
De Wit, S., Debier, M., De Smet, M., McCrea, J., Stone, J., Carides, A., ...
To evaluate a potential pharmacokinetic interaction of coadministration of fluconazole, and indinavir, a human immunodeficiency virus (HIV) protease inhibitor, 13 patients were enrolled in a...
De Wit, S., O’Doherty, E., Edwards, J., Yates, R., Smith, R. P., Clumeck, A. N.
D0870 is a triazole with a broad antifungal spectrum, and it has been shown to have both in vitro and in vivo activities against wild-type and fluconazole-resistant strains of Candida albicans....
Revets, H, Marissens, D, De Wit, S, Lacor, P, Clumeck, N, Lauwers, S, ...
Three commercial assays for quantifying plasma human immunodeficiency virus type 1 (HIV-1) RNA were evaluated. The assays differed in their sample volumes, the means of preparing samples, and methods...
De Wit, S, Hermans, P, Sommereijns, B, O'Doherty, E, Westenborghs, R, ...
The pharmacokinetics of oral administration of R 82913, or tetrahydroimidazol [4,5,1-jk]-benzodiazepin-2(1H)-one or -thione (TIBO), was compared with those of intravenous administration in five AIDS...
De Wit, S., Debier, M., De Smet, M., McCrea, J., Stone, J., Carides, A., ...
To evaluate a potential pharmacokinetic interaction of coadministration of fluconazole, and indinavir, a human immunodeficiency virus (HIV) protease inhibitor, 13 patients were enrolled in a...
De Wit, S., O’Doherty, E., Edwards, J., Yates, R., Smith, R. P., Clumeck, A. N.
D0870 is a triazole with a broad antifungal spectrum, and it has been shown to have both in vitro and in vivo activities against wild-type and fluconazole-resistant strains of Candida albicans....
Revets, H, Marissens, D, De Wit, S, Lacor, P, Clumeck, N, Lauwers, S, ...
Three commercial assays for quantifying plasma human immunodeficiency virus type 1 (HIV-1) RNA were evaluated. The assays differed in their sample volumes, the means of preparing samples, and methods...
De Wit, S, Hermans, P, Sommereijns, B, O'Doherty, E, Westenborghs, R, ...
The pharmacokinetics of oral administration of R 82913, or tetrahydroimidazol [4,5,1-jk]-benzodiazepin-2(1H)-one or -thione (TIBO), was compared with those of intravenous administration in five AIDS...
Moore, E., O'Flaherty, D., Heuvelmans, H., Seaman, J., Veeken, H., De Wit, S., ...
OBJECTIVE: To compare the use of generic and proprietary sodium stibogluconate for the treatment of visceral leishmaniasis (kala-azar). METHODS: A total of 102 patients with confirmed kala-azar were...